Probing interactions of Vpu from HIV-1 with amiloride-based compounds

被引:9
|
作者
Rosenberg, Matthew R. [1 ]
Weaver, Llara M. [1 ]
Casarotto, Marco G. [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia
来源
基金
澳大利亚研究理事会;
关键词
Vpu; Viral ion channel; HIV-AIDS; Drug binding; Amiloride; VIRUS PROTEIN-U; M2; ION-CHANNEL; AMINO-ACID SUBSTITUTION; TRANS-MEMBRANE DOMAIN; TRANSMEMBRANE DOMAIN; PHOSPHOLIPID-BILAYERS; BINDING-SITES; FULL-LENGTH; DERIVATIVES; DEGRADATION;
D O I
10.1016/j.bbamem.2015.12.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Viral ion channels or viroporins are short membrane proteins that participate in wide-ranging functions including virus replication and entry, assembly, and virus release. One such viroporin is the 81 amino acid residue Vpu protein derived from HIV-1. This protein consists of one transmembrane (TM) and two cytoplasmic helical domains, the former of which oligomerises to form cation-selective ion channels. In this study, we investigate the binding properties of amiloride compounds to Vpu embedded into liposomes using surface plasmon resonance (SPR). We explore the Vpu ion channel inhibitor, hexamethylene amiloride (HMA), as a molecular tool to examine the potential interactive role of key TM residues, Trp23, Ser24, and G1u29, in terms of positioning of these residues on the channel pore and the orientation of its constituent helices. The study provides experimental support that a direct interaction between Ser24 and HMA occurs and that this residue is most likely located in the channel pore. Mutation of Trp23 does not impact HMA affinity suggesting no direct involvement in binding and that this residue is lipid facing. These findings indicate that small molecules such as amilorides are capable of specifically interacting with Vpu ion channels. Although a correlation between ion channel and functional activity cannot be dismissed, alternative mechanisms involving protein-protein interactions may play an important role in the efficacy of these compounds. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 50 条
  • [21] FRET Analysis of the Promiscuous yet Specific Interactions of the HIV-1 Vpu Transmembrane Domain
    Cole, Gregory B.
    Reichheld, Sean E.
    Sharpe, Simon
    BIOPHYSICAL JOURNAL, 2017, 113 (09) : 1992 - 2003
  • [22] Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors
    Stoneham, Charlotte A.
    Singh, Rajendra
    Jia, Xiaofei
    Xiong, Yong
    Guatelli, John
    TRAFFIC, 2017, 18 (08) : 545 - 561
  • [23] Viral channel investigations: The kinetics of Vpu channels from HIV-1
    不详
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2005, 34 (06): : 647 - 647
  • [24] Computational analysis of mutations in the transmembrane region of Vpu from HIV-1
    Candler, A
    Featherstone, M
    Ali, R
    Maloney, L
    Watts, A
    Fischer, WB
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1716 (01): : 1 - 10
  • [25] Vpu from HIV-1 on an atomic scale: experiments and computer simulations
    Fischer, WB
    FEBS LETTERS, 2003, 552 (01) : 39 - 46
  • [26] Structural modeling of Vpu from HIV-1 based on solid-state NMR observables
    Ahn, SeonJoo
    Lim, GyuTae
    Nam, Seungyoon
    Lee, Jinhyuk
    CHEMICAL PHYSICS LETTERS, 2014, 599 : 116 - 121
  • [27] Potential roles of Nef and Vpu in HIV-1 latency
    Kmiec, Dorota
    Srinivasachar, Smitha
    Kirchhoff, Frank
    FUTURE VIROLOGY, 2019, 14 (04) : 227 - 236
  • [28] HIV-1 Vpu - an ion channel in search of a job
    Strebel, Klaus
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2014, 1838 (04): : 1074 - 1081
  • [29] Insights into the oligomeric structure of the HIV-1 Vpu protein
    Majeed, Saman
    Adetuyi, Oluwatosin
    Borbat, Peter P.
    Islam, Md Majharul
    Ishola, Olamide
    Zhao, Bo
    Georgieva, Elka R.
    JOURNAL OF STRUCTURAL BIOLOGY, 2023, 215 (01)
  • [30] HIV-1 Vpu Disarms Natural Killer Cells
    Richard, Jonathan
    Cohen, Eric A.
    CELL HOST & MICROBE, 2010, 8 (05) : 389 - 391